Pacira BioSciences
PCRX
PCRX
210 hedge funds and large institutions have $1.57B invested in Pacira BioSciences in 2019 Q1 according to their latest regulatory filings, with 38 funds opening new positions, 77 increasing their positions, 63 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
210
Holders Change
+2
Holders Change %
+0.96%
% of All Funds
4.55%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.09%
New
38
Increased
77
Reduced
63
Closed
34
Calls
$9.45M
Puts
$5.23M
Net Calls
+$4.22M
Net Calls Change
-$19.3M
Top Buyers
| 1 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
$52.5M |
| 2 |
AC
Armistice Capital
New York
|
$40.8M |
| 3 |
Renaissance Technologies
New York
|
$40.5M |
| 4 |
D.E. Shaw & Co
New York
|
$35.9M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$31.8M |
